BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1895531)

  • 21. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evaluation of delapril in Japan. Report from the Japan Study Group on Delapril.
    Ogihara T; Kaneko Y; Ikeda M; Yamada K; Omae T; Arakawa K; Ishii M; Yoshinaga K; Kumahara Y; Kokubu T
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):42S-45S. PubMed ID: 2009147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [ACE inhibitors and cough].
    Kobayashi S; Kawakami Y; Hirabayashi T
    Kokyu To Junkan; 1990 Aug; 38(8):763-7. PubMed ID: 2218084
    [No Abstract]   [Full Text] [Related]  

  • 24. Chronic cough due to angiotensin-converting enzyme inhibitors.
    Nuss DW; Lyons GD; Joseph JJ
    Ear Nose Throat J; 1990 Sep; 69(9):649, 651. PubMed ID: 2245793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefits of delapril in hypertensive patients along the cardiovascular continuum.
    González-Juanatey JR; Cordero A
    Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):271-81. PubMed ID: 23469905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril. A controlled retrospective cohort study.
    Wood R
    Br J Clin Pharmacol; 1995 Mar; 39(3):265-70. PubMed ID: 7619667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The safety and tolerability of quinapril.
    Knapp LE; Frank GJ; McLain R; Rieger MM; Posvar E; Singer R
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S47-55. PubMed ID: 1691407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cough caused by angiotensin-converting enzyme inhibitors. A series of cases collected by spontaneous notification of adverse reactions].
    Capellà D; Torres F; Avila P; Moreno V; Laporte JR
    Med Clin (Barc); 1991 Feb; 96(4):126-8. PubMed ID: 2023485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Congestive heart failure in elderly patients: controlled study of delapril versus captopril.
    Acanfora D; Lanzillo T; Papa A; Longobardi G; Furgi G; Rengo C; Melillo E; Rengo F
    Am J Cardiol; 1995 Jun; 75(18):37F-43F. PubMed ID: 7778533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin converting enzyme (ACE) inhibitor-induced cough and substance P.
    Tomaki M; Ichinose M; Miura M; Hirayama Y; Kageyama N; Yamauchi H; Shirato K
    Thorax; 1996 Feb; 51(2):199-201. PubMed ID: 8711657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
    Giles TD; Fisher MB; Rush JE
    Am J Med; 1988 Sep; 85(3B):44-7. PubMed ID: 2844087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchial hyperreactivity in patients who cough after receiving angiotensin converting enzyme inhibitors.
    Bucknall CE; Neilly JB; Carter R; Stevenson RD; Semple PF
    Br Med J (Clin Res Ed); 1988 Jan; 296(6615):86-8. PubMed ID: 2827838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure.
    Dyadyk AI; Bagriy AE; Lebed IA; Yarovaya NF; Schukina EV; Taradin GG
    Nephrol Dial Transplant; 1997 May; 12(5):945-51. PubMed ID: 9175047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Undesirable effects and interaction to angiotensin converting enzyme inhibitors therapy].
    Ionescu SD; Sandru V; Leuciuc E; Manea P; Burdujan A; Tovarniţchi S; Cosovanu A
    Rev Med Chir Soc Med Nat Iasi; 2002; 106(1):128-31. PubMed ID: 12635373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of cough during angiotensin-converting enzyme inhibitor therapy.
    Goldszer RC; Lilly LS; Solomon HS
    Am J Med; 1988 Dec; 85(6):887. PubMed ID: 2848417
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dry cough from ACE inhibitors].
    Schröder H
    Med Monatsschr Pharm; 2005 Sep; 28(9):321-2. PubMed ID: 16163883
    [No Abstract]   [Full Text] [Related]  

  • 38. [Blood pressure and metabolic response to converting enzyme inhibitor in hypertensive patients: comparison between delapril and captopril].
    Chu TS; Wu MS; Chen YM; Wu KD
    J Formos Med Assoc; 1992 Dec; 91 Suppl 4():S288-92. PubMed ID: 1363526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo.
    Rake EC; Breeze E; Fletcher AE
    J Hum Hypertens; 2001 Dec; 15(12):863-7. PubMed ID: 11773989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
    Kubo SH; Cody RJ
    Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.